UNSPSC 51433000: Antihypertensive oxazoles

Antihypertensive drugs made from five-membered heterocyclic ring structures containing an oxygen in the 1-position and a nitrogen in the 3-position.

UNSPSC 51433000 Antihypertensive oxazoles is a Class code under which state and local governments procure emergency medications and pharmaceutical products for fire rescue, public health, and statewide pharmacy benefit programs. Recent solicitations show that the code encompasses both acute-care emergency medications (such as labetalol, diltiazem, adenosine, and epinephrine) used by fire departments and emergency medical services, and broader multi-source generic pharmaceutical supply agreements serving state agencies and health systems. Issuing bodies include municipal purchasing departments (city fire rescue operations), state health commissions, and state procurement cooperatives that aggregate purchasing across multiple jurisdictions. The City of Tampa's Purchasing Department and the Texas Health and Human Services Commission are among recent buyers, while the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP) administers a cooperative vehicle serving state and local facilities across participating states including Oregon.

Recent activity spans Florida, Texas, and the Upper Midwest. The City of Tampa posted an invitation to bid (Solicitation 26P00188) on April 24, 2026, with response due April 8, 2026, seeking 370 units of labetalol HCI 100mg vials, 1,810 units of epinephrine 1:10,000 injections, 330 units of adenosine 6mg vials, and 1,020 units of diltiazem 25mg vials for Tampa Fire Rescue, with an estimated contract value of $40,000 and a one-year term plus two optional renewals. The Texas Health and Human Services Commission issued a Request for Information (RFI HHS0017013) on April 3, 2026, exploring vendor capabilities for direct-to-manufacturer prescription programs outside traditional pharmacy benefit manager and group purchasing organization channels. The Minnesota Department of Administration's Office of State Procurement, administering MMCAP, issued an RFP (S1070000015802) due March 26, 2026, to establish multi-award contracts for generic multi-source pharmaceuticals and OTC products through three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health, and Morris & Dickson), with contract terms effective July 1, 2026, and award decisions based 75 percent on price competitiveness.